The news team covers a wide array of topics within the biopharmaceutical space including but not limited to:
Expected Clinical Results
Upcoming Drug Approvals
Drug Pricing and Uptake
Regulatory and Reimbursement Trends
Potential M&As, Financing and IPOs
Licensing and Partnership Opportunities
CRO & CMO Activity
Unmatched Access to Key Sources
BioPharm Insight journalists have unparalleled access to global key opinion leaders. Through their interviews with clinical trial investigators, physicians, researchers, consultants, lawyers, and C-level executives, BioPharm Insight’s news team is able to provide the most comprehensive and insightful news coverage in the industry.
BioPharm Insight's news is independent from external influences with an ad-free web platform and separation between its news team and commercial side of the business. News sources are never compensated for their interviews and BioPharm Insight and editors verify facts and source credentials to ensure each article is 100% objective.